SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO selloff dominates discussion, with traders citing successive insider and IPO lockup share releases and a TD Cowen price-target cut, alongside concerns about OpenAI customer concentration, Nvidia competition, and the companys ability to scale. Bears see continued selling pressure and execution risks, while bulls argue the stock is oversold and point to its cash position, backlog, and wafer-scale technology.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs steep decline to new lows is being discussed alongside concerns about Trumps falling approval and the approaching midterms, with traders also pointing to weak business fundamentals and Truth Social engagement. The conversation is overwhelmingly bearish, though some see the selloff as a potential trading opportunity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff has focused discussion on its heavy debt, costly financing needs and insider selling, alongside concerns about broader weakness in AI infrastructure stocks. Traders are split between fears of dilution or default and hopes that contracted AI demand, analyst support and buying near recent lows could underpin a recovery.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious 15th-anniversary LinkedIn post prompted speculation that its next chapter language hinted at REGAL trial news or a buyout, while skeptics viewed it as routine reassurance. The main focus remains the blinded Phase 3 REGAL trial, last publicly reported at 78 of the 80 deaths needed to trigger final analysis; neither the outcome nor a potential deal is confirmed.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recent climb to a 52-week high is drawing attention as traders watch for a break above the $30 level, citing product and pipeline progress, including an expanded Tukysa indication and clinical updates. Bulls see a turnaround supported by defensive-sector interest and the dividend, while skeptics question the rallys durability given patent-expiration concerns and resistance near $30.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention as traders position around its Q3 earnings report, with options activity reflecting uncertainty rather than a clear directional consensus. The debate weighs weaker vehicle sales and EV demand against expectations that pricing and product mix could support profitability.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCells Fit Energy data-center project and broader AI-driven demand for on-site power are fueling interest, alongside expectations for a manufacturing ramp and discussion of elevated short interest. Bulls point to the project pipeline and Alex Meruelos reported 7.5% stake, while skeptics question whether opportunities will become firm orders and profitable execution amid dilution and management concerns.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Interim ARO-MAPT data showing substantial tau reduction after a subcutaneous dose has focused attention on whether Arrowheads RNAi platform can deliver treatments across the blood-brain barrier. Many traders view the results as important platform validation, while others are frustrated by the muted share-price response and debate how much value the CNS opportunity merits.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention amid a sharp semiconductor pullback and rebound, with traders debating whether AI infrastructure spending and debt-backed data-center expansion can generate adequate returns. Bearish concerns about financing and profitabilityespecially around CoreWeavecontrast with dip-buyers pointing to continued compute demand and Nvidias quantum-computing work.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths better-than-expected quarterly results and raised full-year outlook, alongside improved medical-cost trends, are driving attention. Bulls view the report as evidence of a turnaround and point to defensive-sector demand, while skeptics note the post-earnings selloff and lingering concerns about Medicare Advantage costs and regulatory risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Vanguard Morningstar Mid-Cap Value ETF (VOE) Be on Your Investing Radar?

Mid-Cap Value ETF (VOE) Hits a New 52-Week High

VOE hits a fresh 52-week high as investors flock to value amid rising geopolitical risks. Can the rally continue?

Should Vanguard Mid-Cap Value Index Fund ETF Shares (VOE) Be on Your Investing Radar?

Opportunity Beckons With This Vanguard Value ETF and It's Not The One You're Thinking Of

Key PointsWith value stocks on the mend, the Vanguard Mid-Cap Value ETF should be turning more heads...

What’s Driving DOCU Stock Up After Hours?

Equity

DOCU’s fourth quarter total revenue was $836.9 million, an 8% year-over-year increase helped by strong performance in subscription revenue and professional services.


CBOE Plans To Launch Near 24 Hour 5-Day Trading In Bid To Catch Up With HOOD

Cboe is preparing to launch in December 2026, pending regulatory approval of its filing, and contingent upon the readiness of required industry infrastructure providers.  


State Street Shares Rise As Exec Expects Q1 2026 Revenue To Exceed Former Expectations

“We'll have a lot more to say and share on our full year expectations when we get back together again in about a month in mid-April to talk about the Q1 results,” the bank's executive said in a conference.


Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?

Vanguard Index Funds - Vanguard Morningstar Mid-Cap Value ETF

Bearish Sentiment

<ul class="summary-bullets"><li>Its billings during the quarter were $1.0 billion, a 10% year-over-year increase.&nbsp;</li><li>DocuSign sees FY27 revenue $3.484 billion-$3.496 billion, compared to Wall Street estimates $3.42 billion.</li><li>It expects FY27 annual recurring revenue year-over-year growth rate 8.25%-8.75% and adjusted gross margin 81.5%-82.0%.&nbsp;</li></ul><p>DocuSign (DOCU) shares jumped in extended hours of trading on Tuesday after it reported fourth-quarter (Q4) revenue higher than Street expectations.&nbsp;</p><p>DOCU posted&nbsp;Q4 revenue of $836.9 million, an 8% year-over-year increase,&nbsp;while analysts on average expected revenue of $827.33 million, according to data from Stocktwits.&nbsp;The company said the revenue was bolstered by strong performance in subscription revenue and professional services.&nbsp;</p><p>Shares of DOCU were up 1.4%, at the time of writing.&nbsp;</p><h2 class="st-heading-2">Q4 Earnings Snapshot</h2><p>The company said adjusted net income per diluted share was $1.01 on 205 million shares outstanding, compared to $0.86 on 215 million shares outstanding in the same period last year.</p><p>Its billings during the quarter were $1.0 billion, a 10% year-over-year increase.&nbsp;</p><p>"Docusign's AI-native IAM platform has established clear market leadership as the agreement system of action for companies of all sizes," said Allan Thygesen, CEO of Docusign. "In 2026, customers using IAM represented over $350 million in ARR, and Docusign reached record highs for operating margin and free cash flow."</p><h2 class="st-heading-2">Outlook</h2><p>DocuSign said it expects FY27 revenue of $3.484 billion&nbsp;to $3.496 billion, compared to Wall Street estimates of $3.42 billion. DocuSign also projected Q1 revenue for its FY27 of $822 million to $826 million, according to Wall Street consensus of $813.61 million, as per TheFly.&nbsp;</p><p>It expects FY27 annual recurring revenue year-over-year growth rate of 8.25%-8.75% and adjusted gross margin 81.5%-82.0%.&nbsp;</p><h2 class="st-heading-2">Stock Repurchase</h2><p>Docusign said its board has authorized an increase to its existing stock repurchase program of an additional amount of up to $2.0 billion of Docusign's outstanding common stock.</p><p>The company said as of March 17, 2026, its total remaining authorization under&nbsp;the stock repurchase program is up to $2.6 billion.&nbsp;</p><h2 class="st-heading-2">Retail Reaction</h2><p>Retail sentiment around DOCU shares trended in the ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;</p><p>Shares in the company have fallen 30.7% year to date.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Facade of DocuSign building with logo visible, South of Market, San Francisco, California, June 7, 2024.

DOCU’s fourth quarter total revenue was $836.9 million, an 8% year-over-year increase helped by strong performance in subscription revenue and professional services.

DocuSign Inc

Invesco S&P 500 Equal Weight ETF

Vanguard Mid-Cap Value ETF

Vanguard S&P 500 ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$204.38
Prev Close	$205.77
Open	$205.50
Dividend Yield	N/A
50-Day Moving Average	$204.51
Beta	N/A
Avg. Volume	369,506.11
PE Ratio	N/A

52-Week High	$211.07
52-Week Low	$168.76
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VOE Fundamentals